The role of elevated alanine aminotransferase (ALT) FasL and atherogenic dyslipidemia in type II diabetes mellitus

摘要

ObjectivesMany cross-sectional and prospective studies have shown that type 2 diabetes mellitus is a probable cause of non-alcoholic fatty liver disease (NAFLD) with fibrosis and cirrhosis. This research aimed to examine the plasma amino transaminase levels as biomarkers of NAFLD and their association with apoptosis markers (Fas and FasL) as well as the lipid profile in type II diabetic patients.